Vontobel Holding Ltd. Abb Vie Inc. Transaction History

Vontobel Holding Ltd.

$29.2 Billion
Q3 2024

A detailed history of Vontobel Holding Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 134,678 shares of ABBV stock, worth $24.2 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

134,678

Previous 132,591 1.57%

Holding current value

$24.2 Million

Previous $22.7 Million 16.95%

% of portfolio

0.09%

Previous 0.08%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$163.84 - $199.33 $341,934 - $416,001	2,087 Added 1.57%	134,678 $26.6 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $5.43 Million - $6.34 Million	-35,099 Reduced 20.93%	132,591 $22.7 Million
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $23.9 Million - $27.2 Million	-149,423 Reduced 47.12%	167,690 $30.5 Million
Q4 2023 Jun 03, 2024	SELL	$137.6 - $154.97 $398,352 - $448,638	-2,895 Reduced 1.52%	187,828 $29.1 Million
Q4 2023 Jan 29, 2024	SELL	$137.6 - $154.97 $200,896 - $226,256	-1,460 Reduced 0.46%	317,113 $49.1 Million
Q3 2023 Jun 03, 2024	SELL	$133.59 - $154.65 $2.7 Million - $3.13 Million	-20,233 Reduced 9.59%	190,723 $28.4 Million
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $4.31 Million - $4.99 Million	-32,275 Reduced 9.2%	318,573 $47.5 Million
Q2 2023 Jun 03, 2024	SELL	$132.51 - $164.9 $12,058 - $15,005	-91 Reduced 0.04%	210,956 $28.4 Million
Q2 2023 Jul 24, 2023	SELL	$132.51 - $164.9 $395,277 - $491,896	-2,983 Reduced 0.84%	350,848 $47.3 Million
Q1 2023 Jun 03, 2024	BUY	$144.61 - $166.54 $6.27 Million - $7.22 Million	43,357 Added 25.86%	211,047 $33.6 Million
Q1 2023 Apr 12, 2023	BUY	$144.61 - $166.54 $23.7 Million - $27.3 Million	163,840 Added 86.24%	353,831 $56.4 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $2.2 Million - $2.64 Million	-15,931 Reduced 7.74%	189,991 $30.7 Million
Q3 2022 Nov 04, 2022	BUY	$134.21 - $153.93 $5.11 Million - $5.86 Million	38,043 Added 22.66%	205,922 $27.6 Million
Q2 2022 Jul 27, 2022	SELL	$137.62 - $174.96 $963 - $1,224	-7 Reduced -0.0%	167,879 $25.9 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $8.51 Million - $10.6 Million	-64,487 Reduced 27.75%	167,886 $27.5 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $2.94 Million - $3.72 Million	-27,381 Reduced 10.54%	232,373 $31.6 Million
Q3 2021 Oct 29, 2021	BUY	$106.4 - $120.78 $3.55 Million - $4.03 Million	33,389 Added 14.75%	259,754 $28 Million
Q2 2021 Aug 06, 2021	SELL	$105.21 - $117.21 $857,040 - $954,792	-8,146 Reduced 3.47%	226,365 $25.4 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $5.45 Million - $6 Million	53,279 Added 29.4%	234,511 $25.4 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $14.6 Million - $19.7 Million	181,232 New	181,232 $19.4 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Account

Vontobel Holding Ltd. Abb Vie Inc. Transaction History